- Home
- IIPR vs NVCR Comparison
IIPR vs NVCR Comparison
Compare IIPR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IIPR | NVCR |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2016 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IIPR | NVCR |
|---|---|---|
| Price | $48.21 | $12.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $74.67 | $26.42 |
| AVG Volume (30 Days) | 336.9K | ★ 1.1M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | ★ 15.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.24 | N/A |
| Revenue | $276,042,000.00 | ★ $642,269,000.00 |
| Revenue This Year | N/A | $10.64 |
| Revenue Next Year | $1.70 | $5.23 |
| P/E Ratio | $11.30 | ★ N/A |
| Revenue Growth | N/A | ★ 11.17 |
| 52 Week Low | $44.58 | $10.70 |
| 52 Week High | $75.71 | $26.47 |
Technical Indicators
Market Signals| Indicator | IIPR | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 41.19 | 41.21 |
| Support Level | $47.80 | $12.80 |
| Resistance Level | $49.34 | $14.29 |
| Average True Range (ATR) | 1.24 | 0.62 |
| MACD | -0.18 | -0.19 |
| Stochastic Oscillator | 9.59 | 3.52 |
Price Performance
Historical ComparisonAbout IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.